<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-00305</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0065208</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Computational biology</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject><subj-group><subject>RNA processing</subject></subj-group></subj-group><subj-group><subject>Epigenetics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Clinical research design</subject><subj-group><subject>Meta-analyses</subject></subj-group></subj-group><subj-group><subject>Epidemiology</subject><subj-group><subject>Cancer epidemiology</subject></subj-group></subj-group><subj-group><subject>Gastroenterology and hepatology</subject><subj-group><subject>Gastrointestinal cancers</subject></subj-group></subj-group><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Genitourinary tract tumors</subject><subj-group><subject>Renal cell carcinoma</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">Pre-miR-27a rs895819A/G Polymorphisms in Cancer</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Xu</surname><given-names>Qian</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>He</surname><given-names>Cai-yun</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>Jing-wei</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yuan</surname><given-names>Yuan</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><addr-line>Tumor Etiology and Screening Department of Cancer Institute and General Surgery, the First Affiliated Hospital of China Medical University, the Key Laboratory of Cancer Etiology and Prevention in Liaoning Province, Shenyang, Liaoning Province, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Toland</surname><given-names>Amanda Ewart</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Ohio State University Medical Center, United States of America</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">yyuan3@mai.cmu.edu.cn</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: YY. Performed the experiments: QX. Analyzed the data: QX CH. Contributed reagents/materials/analysis tools: QX CH. Wrote the paper: QX. Revised the manuscript: QX CH JL YY.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2013</year></pub-date>
<pub-date pub-type="epub"><day>7</day><month>6</month><year>2013</year></pub-date>
<volume>8</volume>
<issue>6</issue>
<elocation-id>e65208</elocation-id>
<history>
<date date-type="received"><day>25</day><month>12</month><year>2012</year></date>
<date date-type="accepted"><day>23</day><month>4</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2013</copyright-year>
<copyright-holder>Xu et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract><sec>
<title>Background</title>
<p>MicroRNAs (miRNAs) negatively regulate the 3′ untranslated region (3′-UTR) of coding genes by suppressing translation or degrading mRNAs, and they act as oncogenes or tumor suppressors. Recently, several studies investigated the association between pre-miR-27a rs895819 polymorphism and the risks of various cancers, but the results were inconsistent.</p>
</sec><sec>
<title>Methodology/Principal Findings</title>
<p>We conducted a meta-analysis of 13 studies that included 6501 cancer cases and 7571 controls to address this association. Overall, this meta-analysis showed that the pre-miR-27a rs895819 A/G polymorphism was not statistically associated with cancers risk in all genetic models. In the stratified analysis by cancer types, when compared with the ancestral A allele, individuals with the variant G allele was consistently associated with reduced risks of breast cancer (OR = 0.92, 95% CI = 0.85–0.99), renal cell cancer (OR = 0.81, 95% CI = 0.67–0.97) and nasopharyngeal cancer (OR = 0.84, 95% CI = 0.72–0.97). Inversely, individuals with the heterozygote AG was associated with an increased risk of digestive tract cancers compared with AA genotype (AG vs. AA: OR = 1.16, 95% CI = 1.01–1.32). In the stratified analysis by ethnicity, the pre-miR-27a rs895819 polymorphism showed statistically significant association with decreased risks of cancers in Caucasians (G vs. A allele: OR = 0.90, 95% CI = 0.83–0.97; AG vs. AA: OR = 0.84, 95% CI = 0.75–0.94; AG/GG vs. AA: OR = 0.85, 95% CI = 0.76–0.94) but not in Asians.</p>
</sec><sec>
<title>Conclusion/Significance</title>
<p>This meta-analysis suggests that the pre-miR-27a rs895819 polymorphism may contribute to the susceptibilities of some specific-type of cancers, including breast cancer, renal cell cancer, nasopharyngeal cancer and digestive tract cancers, as well as the susceptibilities of cancers in Caucasians to some extent.</p>
</sec></abstract>
<funding-group><funding-statement>This work is supported by grants from the National Key Basic Research Program of China (973 Program ref no. 2010CB529304, <ext-link ext-link-type="uri" xlink:href="http://www.973.gov.cn/Default_3.aspx" xlink:type="simple">http://www.973.gov.cn/Default_3.aspx</ext-link>), the National Natural Science Foundation of China (Ref No. 31200968, <ext-link ext-link-type="uri" xlink:href="http://www.nsfc.gov.cn/Portal0/default152.htm" xlink:type="simple">http://www.nsfc.gov.cn/Portal0/default152.htm</ext-link>), and the Science Technology Project in Liaoning Province (Ref No. 2011225002, <ext-link ext-link-type="uri" xlink:href="http://kjjh.lninfo.gov.cn/" xlink:type="simple">http://kjjh.lninfo.gov.cn/</ext-link>). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="7"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>MicroRNAs (miRNAs) are RNAs that are 18–23 nucleotides long that participate in the transcriptional regulation of eukaryotic genes <xref ref-type="bibr" rid="pone.0065208-Zanetti1">[1]</xref>, which is associated with post-transcriptional modifications that lead to the mRNA’s degradation or the translational repression of the targeted genes <xref ref-type="bibr" rid="pone.0065208-Khvorova1">[2]</xref>. miRNA genes are transcribed to a hairpin-shaped RNA form named pri-miRNA <xref ref-type="bibr" rid="pone.0065208-Higgins1">[3]</xref>, which is processed by an endonuclease, Drosha, to form a pre-miRNA that is 60–70 nucleotides long <xref ref-type="bibr" rid="pone.0065208-Lee1">[4]</xref>. The pre-miRNAs are cleaved by an endonuclease, Dicer, to form the mature miRNA, which functions as a gene regulator <xref ref-type="bibr" rid="pone.0065208-Schwarz1">[5]</xref>. The variation of the pri-, pre-, and mature miRNA through physiological processes may cause the incidence and development of a tumor.</p>
<p>miRNAs are transcribed from a gene intron and/or intergenic region. Polymorphisms exist in the pri-, pre-, and mature miRNA genes that can potentially influence the processing of maturing miRNAs, broadly affecting the miRNA function <xref ref-type="bibr" rid="pone.0065208-Duan1">[6]</xref>. The first research focused on pre-miRNA polymorphisms screened 323 single nucleotide polymorphisms (SNPs) in 227 miRNA genes according to bioinformation by Duan et al. <xref ref-type="bibr" rid="pone.0065208-Duan1">[6]</xref>. From then on, scholars all focused on 3 SNP sites in the field of the association between miRNA polymorphism and cancers, hsa-pre-miR-146a rs2910164, hsa-pre-miR-196a2 rs11614913, and hsa-miR-499 rs374644, and several meta analyses reported that these 3 sites were associated with cancer risks <xref ref-type="bibr" rid="pone.0065208-Wang1">[7]</xref>–<xref ref-type="bibr" rid="pone.0065208-Gao1">[16]</xref>. The miR-27a rs895819 A/G polymorphism is located in the loop of the pre-miRNA, and the variation from A to G could cause a change in the minimum free energy (MFE). Therefore, this SNP may affect the function of the miRNA to some extent. However, the results regarding its association with cancer risk are conflicting. The majority of studies reported that the variant allele could decrease the cancer risk <xref ref-type="bibr" rid="pone.0065208-Kontorovich1">[17]</xref>–<xref ref-type="bibr" rid="pone.0065208-Shi1">[19]</xref>, but some studies reported different viewpoints. A few studies reported that the association between the variant G allele and cancer risk was insignificant; these studies denied the protective role of the G allele <xref ref-type="bibr" rid="pone.0065208-Zhang1">[20]</xref>–<xref ref-type="bibr" rid="pone.0065208-Catucci1">[22]</xref>. Moreover, some studies reported that the variant G allele was a risk allele. For example, 2 studies using samples from the same continent analyzed the AG and GG genotypes for the risk of gastric cancer and compared the risk with that for the AA wild-type genotype. One study found that the AG and GG genotypes increased the risk of gastric cancer <xref ref-type="bibr" rid="pone.0065208-Sun1">[23]</xref>, and the other study found the opposite result <xref ref-type="bibr" rid="pone.0065208-Zhou1">[24]</xref>. Therefore, the comprehensive analysis that integrates all individual studies is still required. To enhance the efficiency of meta-analysis on the risk of cancers and investigate whether this rs895819 polymorphism was associated with the gastric cancer risk, an unpublished case-control study on gastric cancer that was performed by Qian Xu et al at the Tumor Etiology and Screening Department of Cancer Institute and General Surgery in the First Affiliated Hospital of China Medical University, Shenyang, China was collected. Overall, 13 datasets consisted of 6501 cases with cancers and 7571 controls were included in our study. These data should be combined to expand our understanding of the pre-miR-27a rs895819 SNP, which may provide some evidence for the future research. Thus, in this study we conducted a meta-analysis to combine all of the available studies and validate whether the miR-27a A/G polymorphism contributes to the risks of cancers.</p>
</sec><sec id="s2" sec-type="methods">
<title>Methods</title>
<sec id="s2a">
<title>Publication Search</title>
<p>A systematic literature search was performed for all articles on the association between pre-miR-27a rs895819 polymorphism and cancer risks up to March 15th, 2013. The PubMed databases, Chinese National Knowledge Infrastructure (CNKI) and Web of Science were used simultaneously. The following key words were used: “miR-27a”, “cancer/carcinoma/tumor/neoplasm”, “rs895819” and “polymorphism” by two independent investigators Qian Xu and Cai-yun He. All the studies met the following criteria: (1) case-control study; (2) the association between miR-27a polymorphism and cancer risks was explored; and (3) genotype frequency was available. The major exclusion criteria were: (1) duplicate data, (2) the study only for cancer samples or for precancerous disease compared with controls, and (3) the subjects in control group were high-risk individuals with some gene mutations.</p>
</sec><sec id="s2b">
<title>Data Extraction</title>
<p>Two of the authors (Qian Xu and Cai-yun He) extracted all data independently, complied with the selection criteria, and reached a consensus on all items. The following items were collected: first author’s name, year of publication, country of origin, ethnicity, cancer type, language, genotyping method, source of control groups (population- or hospital-based), and total number of cases and controls, and genotype distributions in cases and controls. Meanwhile, we categorized gastric cancer, colorectal cancer and liver cancer into ‘digestive tract cancer’ for the stratified analysis.</p>
</sec><sec id="s2c">
<title>Statistics</title>
<p>Firstly, the genotype frequencies of miR-27a polymorphism for Hardy-Weinberg equilibrium (HWE) were assessed by the Chi-square test in controls and a <italic>P</italic>&lt;0.05 was considered as significant disequilibrium. The strength of the association between the miR-27a polymorphism and cancer risks was estimated by odds ratios (ORs) with 95% confidence intervals (CIs). Statistical heterogeneity among studies was tested by Chi square-based Q test and I<sup>2</sup> <xref ref-type="bibr" rid="pone.0065208-Lau1">[25]</xref>. Heterogeneity was considered significantly when <italic>P</italic>&lt;0.10 was observed in Q test, and I<sup>2</sup> was used to qualify variation in OR attributable to heterogeneity. When heterogeneity exists, a random-effect model based on DerSimonian and Laird method was used to calculated the pooled OR of each study <xref ref-type="bibr" rid="pone.0065208-DerSimonian1">[26]</xref>; otherwise, a fixed-effect model based on the Mantel-Haenszel method was employed <xref ref-type="bibr" rid="pone.0065208-Mantel1">[27]</xref>. Generally, we first evaluated the risks between G allele and cancer risks compared with that for A allele in the codominant model (AG versus AA, GG versus AA), dominant model (AG/GG versus AA) and recessive model (GG versus AG/AA), and allelic comparison (G versus A). We also performed stratification analyses on cancer type (divided into digestive tract cancer, breast cancer, nasopharyngeal cancer and renal cell cancer) and ethnicity (Asian and Caucasian). Meta-regression was further performed to detect the source of heterogeneity. The between-studies variance (τ<sup>2</sup>) was used to quantify the degree of heterogeneity between studies and the percentage of τ<sup>2</sup> was used to describe the extent of heterogeneity explained <xref ref-type="bibr" rid="pone.0065208-Whitehead1">[28]</xref>. The Begg’s rank correlation method was used to statistically assess publication bias <xref ref-type="bibr" rid="pone.0065208-Begg1">[29]</xref> (<italic>P</italic>&lt;0.10 was considered as statistically significant). All analyses were done using STATA software, version 11.0 (STATA Corp., College Station, TX, USA), and all tests were two-sided.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Characteristics of the Studies</title>
<p>A total of 20 articles were found by literature search from the PubMed, CNKI and Web of Science <xref ref-type="bibr" rid="pone.0065208-Kontorovich1">[17]</xref>–<xref ref-type="bibr" rid="pone.0065208-Zhou1">[24]</xref>, <xref ref-type="bibr" rid="pone.0065208-Zhong1">[30]</xref>–<xref ref-type="bibr" rid="pone.0065208-Wang5">[41]</xref>, using different combinations of key terms. As shown in <xref ref-type="fig" rid="pone-0065208-g001">Figure 1</xref>, we excluded nine studies (one was function study <xref ref-type="bibr" rid="pone.0065208-Hirota1">[34]</xref>, one was reduplicate data and showed technique problem <xref ref-type="bibr" rid="pone.0065208-Yang3">[33]</xref>, two were not studied for the rs895819 polymorphism <xref ref-type="bibr" rid="pone.0065208-Yang2">[31]</xref>, <xref ref-type="bibr" rid="pone.0065208-Jahid1">[35]</xref>, one is case-only study <xref ref-type="bibr" rid="pone.0065208-Yoon1">[32]</xref>, two had no qualified cases or controls <xref ref-type="bibr" rid="pone.0065208-Kontorovich1">[17]</xref>, <xref ref-type="bibr" rid="pone.0065208-Arisawa1">[36]</xref>, and two were meta-analyses about the rs895819 SNP <xref ref-type="bibr" rid="pone.0065208-Zhong1">[30]</xref>, <xref ref-type="bibr" rid="pone.0065208-Wang5">[41]</xref>). In addition, our research group provided this meta-analysis with a set of unpublished data regarding the association between rs895819 polymorphism and gastric cancer risk. Accordingly, a total of 13 case-control studies extracted from 11 articles and a set of our unpublished data that met our inclusion criteria were included in the final meta-analysis <xref ref-type="bibr" rid="pone.0065208-Yang1">[18]</xref>–<xref ref-type="bibr" rid="pone.0065208-Zhou1">[24]</xref>, <xref ref-type="bibr" rid="pone.0065208-Zhang2">[37]</xref>–<xref ref-type="bibr" rid="pone.0065208-Wang4">[40]</xref>, which consisted of 6501 cancer cases and 7571 cancer-free controls. The characteristic of each included study was presented in <xref ref-type="table" rid="pone-0065208-t001">Table 1</xref>. Of the enrolled 13 studies, all were matched for age, sex except 4 studies for breast cancer that did not need to match sex; 10 studies investigated in Asians and the other 3 studies investigated in Caucasians; controls in 7 studies were hospital-based and controls of the other studies were population-based or mixed subjects; genotyping methods included PCR-RFLP (3 studies), TaqMan (3 studies), PCR-based single base extension (5 studies) and PCR-direct sequencing (2 studies). 11 out of 13 studies checked genotypes for quality control. Genotype distribution of controls in all studies was consistent with Hardy-Weinberg equilibrium.</p>
<fig id="pone-0065208-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065208.g001</object-id><label>Figure 1</label><caption>
<title>Studies identified in this meta-analysis based on the criteria for inclusion and exclusion.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0065208.g001" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0065208-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065208.t001</object-id><label>Table 1</label><caption>
<title>Characteristics of literatures included in this meta-analysis for miR-27a rs895819A/G polymorphism.</title>
</caption><alternatives><graphic id="pone-0065208-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0065208.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">First author</td>
<td align="left" rowspan="1" colspan="1">Year</td>
<td align="left" rowspan="1" colspan="1">Country</td>
<td align="left" rowspan="1" colspan="1">Ethnicity</td>
<td align="left" rowspan="1" colspan="1">Cancer type</td>
<td align="left" rowspan="1" colspan="1">Language</td>
<td align="left" rowspan="1" colspan="1">Genotyping method</td>
<td align="left" rowspan="1" colspan="1">Source of control groups</td>
<td colspan="2" align="left" rowspan="1">Sample size</td>
<td colspan="4" align="left" rowspan="1">Case</td>
<td colspan="4" align="left" rowspan="1">Control</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> of HWE</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Case</td>
<td align="left" rowspan="1" colspan="1">Control</td>
<td align="left" rowspan="1" colspan="1">AA</td>
<td align="left" rowspan="1" colspan="1">AG</td>
<td colspan="2" align="left" rowspan="1">GG</td>
<td colspan="2" align="left" rowspan="1">AA</td>
<td align="left" rowspan="1" colspan="1">AG</td>
<td align="left" rowspan="1" colspan="1">GG</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Qian Xu</td>
<td align="left" rowspan="1" colspan="1">2013<xref ref-type="table-fn" rid="nt102">*</xref></td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">Gastric cancer</td>
<td align="left" rowspan="1" colspan="1">Chinese<xref ref-type="table-fn" rid="nt102">*</xref></td>
<td align="left" rowspan="1" colspan="1">Sequencing</td>
<td align="left" rowspan="1" colspan="1">PB and HB mixed</td>
<td align="left" rowspan="1" colspan="1">222</td>
<td align="left" rowspan="1" colspan="1">305</td>
<td align="left" rowspan="1" colspan="1">115</td>
<td align="left" rowspan="1" colspan="1">100</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td colspan="2" align="left" rowspan="1"/>
<td align="left" rowspan="1" colspan="1">173</td>
<td align="left" rowspan="1" colspan="1">110</td>
<td align="left" rowspan="1" colspan="1">22</td>
<td align="left" rowspan="1" colspan="1">0.437</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Danni Shi</td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">Renal Cell Cancer</td>
<td align="left" rowspan="1" colspan="1">English</td>
<td align="left" rowspan="1" colspan="1">TaqMan</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">594</td>
<td align="left" rowspan="1" colspan="1">600</td>
<td align="left" rowspan="1" colspan="1">334</td>
<td align="left" rowspan="1" colspan="1">213</td>
<td align="left" rowspan="1" colspan="1">47</td>
<td colspan="2" align="left" rowspan="1"/>
<td align="left" rowspan="1" colspan="1">288</td>
<td align="left" rowspan="1" colspan="1">262</td>
<td align="left" rowspan="1" colspan="1">50</td>
<td align="left" rowspan="1" colspan="1">0.373</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Renata Hezova</td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Czech</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">Colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">English</td>
<td align="left" rowspan="1" colspan="1">TaqMan</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">197</td>
<td align="left" rowspan="1" colspan="1">212</td>
<td align="left" rowspan="1" colspan="1">88</td>
<td align="left" rowspan="1" colspan="1">86</td>
<td align="left" rowspan="1" colspan="1">23</td>
<td colspan="2" align="left" rowspan="1"/>
<td align="left" rowspan="1" colspan="1">93</td>
<td align="left" rowspan="1" colspan="1">94</td>
<td align="left" rowspan="1" colspan="1">25</td>
<td align="left" rowspan="1" colspan="1">0.867</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Irene Catucci</td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Italy</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">Breast cancer</td>
<td align="left" rowspan="1" colspan="1">English</td>
<td align="left" rowspan="1" colspan="1">TaqMan</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">1025</td>
<td align="left" rowspan="1" colspan="1">1593</td>
<td align="left" rowspan="1" colspan="1">547</td>
<td align="left" rowspan="1" colspan="1">388</td>
<td align="left" rowspan="1" colspan="1">90</td>
<td colspan="2" align="left" rowspan="1"/>
<td align="left" rowspan="1" colspan="1">803</td>
<td align="left" rowspan="1" colspan="1">633</td>
<td align="left" rowspan="1" colspan="1">157</td>
<td align="left" rowspan="1" colspan="1">0.051</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yuan Zhou</td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">Gastric cancer</td>
<td align="left" rowspan="1" colspan="1">English</td>
<td align="left" rowspan="1" colspan="1">MassARRAY</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">295</td>
<td align="left" rowspan="1" colspan="1">413</td>
<td align="left" rowspan="1" colspan="1">166</td>
<td align="left" rowspan="1" colspan="1">122</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td colspan="2" align="left" rowspan="1"/>
<td align="left" rowspan="1" colspan="1">214</td>
<td align="left" rowspan="1" colspan="1">167</td>
<td align="left" rowspan="1" colspan="1">32</td>
<td align="left" rowspan="1" colspan="1">0.941</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mingwu Zhang</td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">Breast cancer</td>
<td align="left" rowspan="1" colspan="1">English</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">245</td>
<td align="left" rowspan="1" colspan="1">243</td>
<td align="left" rowspan="1" colspan="1">60</td>
<td align="left" rowspan="1" colspan="1">144</td>
<td align="left" rowspan="1" colspan="1">41</td>
<td colspan="2" align="left" rowspan="1"/>
<td align="left" rowspan="1" colspan="1">75</td>
<td align="left" rowspan="1" colspan="1">109</td>
<td align="left" rowspan="1" colspan="1">59</td>
<td align="left" rowspan="1" colspan="1">0.123</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mingwu Zhang</td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">Colorectal cancer</td>
<td align="left" rowspan="1" colspan="1">Chinese</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">463</td>
<td align="left" rowspan="1" colspan="1">468</td>
<td align="left" rowspan="1" colspan="1">248</td>
<td align="left" rowspan="1" colspan="1">178</td>
<td align="left" rowspan="1" colspan="1">37</td>
<td colspan="2" align="left" rowspan="1"/>
<td align="left" rowspan="1" colspan="1">270</td>
<td align="left" rowspan="1" colspan="1">166</td>
<td align="left" rowspan="1" colspan="1">32</td>
<td align="left" rowspan="1" colspan="1">0.351</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Peirao Li</td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">Liver cancer</td>
<td align="left" rowspan="1" colspan="1">Chinese</td>
<td align="left" rowspan="1" colspan="1">SNPstream</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">401</td>
<td align="left" rowspan="1" colspan="1">459</td>
<td align="left" rowspan="1" colspan="1">190</td>
<td align="left" rowspan="1" colspan="1">178</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td colspan="2" align="left" rowspan="1"/>
<td align="left" rowspan="1" colspan="1">233</td>
<td align="left" rowspan="1" colspan="1">190</td>
<td align="left" rowspan="1" colspan="1">36</td>
<td align="left" rowspan="1" colspan="1">0.751</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Peirao Li</td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">Nasopharyngeal cancer</td>
<td align="left" rowspan="1" colspan="1">Chinese</td>
<td align="left" rowspan="1" colspan="1">SNPstream</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">801</td>
<td align="left" rowspan="1" colspan="1">1022</td>
<td align="left" rowspan="1" colspan="1">443</td>
<td align="left" rowspan="1" colspan="1">300</td>
<td align="left" rowspan="1" colspan="1">58</td>
<td colspan="2" align="left" rowspan="1"/>
<td align="left" rowspan="1" colspan="1">505</td>
<td align="left" rowspan="1" colspan="1">431</td>
<td align="left" rowspan="1" colspan="1">86</td>
<td align="left" rowspan="1" colspan="1">0.658</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ping Zhang</td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">Breast cancer</td>
<td align="left" rowspan="1" colspan="1">Chinese</td>
<td align="left" rowspan="1" colspan="1">MassARRAY</td>
<td align="left" rowspan="1" colspan="1">Not mentioned</td>
<td align="left" rowspan="1" colspan="1">376</td>
<td align="left" rowspan="1" colspan="1">190</td>
<td align="left" rowspan="1" colspan="1">196</td>
<td align="left" rowspan="1" colspan="1">150</td>
<td align="left" rowspan="1" colspan="1">30</td>
<td colspan="2" align="left" rowspan="1"/>
<td align="left" rowspan="1" colspan="1">106</td>
<td align="left" rowspan="1" colspan="1">70</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">0.605</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Wenzhang Wang</td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">Liver cancer</td>
<td align="left" rowspan="1" colspan="1">Chinese</td>
<td align="left" rowspan="1" colspan="1">MassARRAY</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">361</td>
<td align="left" rowspan="1" colspan="1">340</td>
<td align="left" rowspan="1" colspan="1">186</td>
<td colspan="2" align="left" rowspan="1">175<xref ref-type="table-fn" rid="nt103">†</xref></td>
<td colspan="2" align="left" rowspan="1"/>
<td align="left" rowspan="1" colspan="1">162</td>
<td colspan="2" align="left" rowspan="1">178<xref ref-type="table-fn" rid="nt103">†</xref></td>
<td align="left" rowspan="1" colspan="1">0.407</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Qingmin Sun</td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">Gastric cancer</td>
<td align="left" rowspan="1" colspan="1">English</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">HB</td>
<td align="left" rowspan="1" colspan="1">304</td>
<td align="left" rowspan="1" colspan="1">304</td>
<td align="left" rowspan="1" colspan="1">115</td>
<td align="left" rowspan="1" colspan="1">135</td>
<td align="left" rowspan="1" colspan="1">54</td>
<td colspan="2" align="left" rowspan="1"/>
<td align="left" rowspan="1" colspan="1">145</td>
<td align="left" rowspan="1" colspan="1">119</td>
<td align="left" rowspan="1" colspan="1">40</td>
<td align="left" rowspan="1" colspan="1">0.053</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rongxi Yang</td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Germany</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">Breast cancer</td>
<td align="left" rowspan="1" colspan="1">English</td>
<td align="left" rowspan="1" colspan="1">Sequencing</td>
<td align="left" rowspan="1" colspan="1">PB</td>
<td align="left" rowspan="1" colspan="1">1217</td>
<td align="left" rowspan="1" colspan="1">1422</td>
<td align="left" rowspan="1" colspan="1">576</td>
<td align="left" rowspan="1" colspan="1">486</td>
<td align="left" rowspan="1" colspan="1">127</td>
<td colspan="2" align="left" rowspan="1"/>
<td align="left" rowspan="1" colspan="1">605</td>
<td align="left" rowspan="1" colspan="1">660</td>
<td align="left" rowspan="1" colspan="1">151</td>
<td align="left" rowspan="1" colspan="1">0.142</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><p>HB, hospital based; PB, population based; HWE, Hardy-Weinberg equilibrium; PCR-RFLP, polymerase chain reaction-restriction fragment length polymorphism.</p></fn><fn id="nt102"><label>*</label><p>the study year when this unpublished data was finished in a Chinese population.</p></fn><fn id="nt103"><label>†</label><p>only the data of dominant model could get, so this study was only analyzed when the dominant model was used.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b">
<title>Quantitative Synthesis</title>
<p>First, all the eligible studies were pooled to estimate the association strength of mir-27a rs895819 polymorphism with the overall risk of all types of cancers. No statistically significant association was found in all genetic models (<xref ref-type="table" rid="pone-0065208-t002">Table 2</xref>). We further performed stratification analysis based on different cancer types and different ethnicities (<xref ref-type="table" rid="pone-0065208-t002">Table 2</xref>).</p>
<table-wrap id="pone-0065208-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065208.t002</object-id><label>Table 2</label><caption>
<title>Pooled ORs and 95% CIs of the overall and stratified meta-analyses.</title>
</caption><alternatives><graphic id="pone-0065208-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0065208.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Variables</td>
<td align="left" rowspan="1" colspan="1">N</td>
<td colspan="3" align="left" rowspan="1">AG vs. AA</td>
<td colspan="3" align="left" rowspan="1">GG vs. AA</td>
<td colspan="3" align="left" rowspan="1">AG/GG vs. AA</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="3" align="left" rowspan="1">GG vs. AA/AG</td>
<td colspan="3" align="left" rowspan="1">G vs. A</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">OR(95% CI)</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic><xref ref-type="table-fn" rid="nt105">a</xref></td>
<td align="left" rowspan="1" colspan="1">I<sup>2</sup>(%)</td>
<td align="left" rowspan="1" colspan="1">OR(95% CI)</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic><xref ref-type="table-fn" rid="nt105">a</xref></td>
<td align="left" rowspan="1" colspan="1">I<sup>2</sup>(%)</td>
<td align="left" rowspan="1" colspan="1">N<xref ref-type="table-fn" rid="nt108">d</xref></td>
<td align="left" rowspan="1" colspan="1">OR(95% CI)</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic><xref ref-type="table-fn" rid="nt105">a</xref></td>
<td align="left" rowspan="1" colspan="1">I<sup>2</sup>(%)</td>
<td align="left" rowspan="1" colspan="1">OR(95% CI)</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic><xref ref-type="table-fn" rid="nt105">a</xref></td>
<td align="left" rowspan="1" colspan="1">I<sup>2</sup>(%)</td>
<td align="left" rowspan="1" colspan="1">OR(95% CI)</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic><xref ref-type="table-fn" rid="nt105">a</xref></td>
<td align="left" rowspan="1" colspan="1">I<sup>2</sup>(%)</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">All cancers</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">1.01</td>
<td align="left" rowspan="1" colspan="1">0.894</td>
<td align="left" rowspan="1" colspan="1">70.0 <xref ref-type="table-fn" rid="nt107">c</xref></td>
<td align="left" rowspan="1" colspan="1">0.90</td>
<td align="left" rowspan="1" colspan="1">0.080</td>
<td align="left" rowspan="1" colspan="1">46.1<xref ref-type="table-fn" rid="nt106">b</xref></td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">0.98</td>
<td align="left" rowspan="1" colspan="1">0.685</td>
<td align="left" rowspan="1" colspan="1">65.2 <xref ref-type="table-fn" rid="nt107">c</xref></td>
<td align="left" rowspan="1" colspan="1">0.91</td>
<td align="left" rowspan="1" colspan="1">0.123</td>
<td align="left" rowspan="1" colspan="1">43.8<xref ref-type="table-fn" rid="nt106">b</xref></td>
<td align="left" rowspan="1" colspan="1">0.96</td>
<td align="left" rowspan="1" colspan="1">0.403</td>
<td align="left" rowspan="1" colspan="1">58.8 <xref ref-type="table-fn" rid="nt107">c</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.88–1.16)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.79–1.01)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.86–1.10)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.81–1.03)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.88–1.05)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cancer type</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Digestive tractcancer</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1"><bold>1.16</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>0.031</bold></td>
<td align="left" rowspan="1" colspan="1">0.0 <xref ref-type="table-fn" rid="nt106">b</xref></td>
<td align="left" rowspan="1" colspan="1">0.90</td>
<td align="left" rowspan="1" colspan="1">0.667</td>
<td align="left" rowspan="1" colspan="1">70.7 <xref ref-type="table-fn" rid="nt107">c</xref></td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">1.08</td>
<td align="left" rowspan="1" colspan="1">0.181</td>
<td align="left" rowspan="1" colspan="1">43.0 <xref ref-type="table-fn" rid="nt106">b</xref></td>
<td align="left" rowspan="1" colspan="1">0.86</td>
<td align="left" rowspan="1" colspan="1">0.471</td>
<td align="left" rowspan="1" colspan="1">67.6 <xref ref-type="table-fn" rid="nt107">c</xref></td>
<td align="left" rowspan="1" colspan="1">1.06</td>
<td align="left" rowspan="1" colspan="1">0.403</td>
<td align="left" rowspan="1" colspan="1">58.4 <xref ref-type="table-fn" rid="nt107">c</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1"><bold>(1.01–1.32)</bold></td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.57–1.43)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.96–1.21)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.56–1.31)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.91–1.23)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Breast cancer</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">1.01</td>
<td align="left" rowspan="1" colspan="1">0.945</td>
<td align="left" rowspan="1" colspan="1">77.1 <xref ref-type="table-fn" rid="nt107">c</xref></td>
<td align="left" rowspan="1" colspan="1">0.88</td>
<td align="left" rowspan="1" colspan="1">0.154</td>
<td align="left" rowspan="1" colspan="1">0.0 <xref ref-type="table-fn" rid="nt106">b</xref></td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">0.96</td>
<td align="left" rowspan="1" colspan="1">0.706</td>
<td align="left" rowspan="1" colspan="1">66.2 <xref ref-type="table-fn" rid="nt107">c</xref></td>
<td align="left" rowspan="1" colspan="1">0.90</td>
<td align="left" rowspan="1" colspan="1">0.210</td>
<td align="left" rowspan="1" colspan="1">16.4 <xref ref-type="table-fn" rid="nt106">b</xref></td>
<td align="left" rowspan="1" colspan="1"><bold>0.92</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>0.023</bold></td>
<td align="left" rowspan="1" colspan="1">0.0 <xref ref-type="table-fn" rid="nt106">b</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.78–1.30)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.74–1.05)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.79–1.18)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.76–1.06)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1"><bold>(0.85–0.99)</bold></td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Renal Cell Cancer</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1"><bold>0.70</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>0.004</bold></td>
<td align="left" rowspan="1" colspan="1">/</td>
<td align="left" rowspan="1" colspan="1">0.81</td>
<td align="left" rowspan="1" colspan="1">0.336</td>
<td align="left" rowspan="1" colspan="1">/</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1"><bold>0.72</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>0.004</bold></td>
<td align="left" rowspan="1" colspan="1">/</td>
<td align="left" rowspan="1" colspan="1">0.95</td>
<td align="left" rowspan="1" colspan="1">0.790</td>
<td align="left" rowspan="1" colspan="1">/</td>
<td align="left" rowspan="1" colspan="1"><bold>0.81</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>0.019</bold></td>
<td align="left" rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1"><bold>(0.55–0.89)</bold></td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.53–1.24)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1"><bold>(0.57–0.90)</bold></td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.62–1.43)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1"><bold>(0.67–0.97)</bold></td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Nasopharyngealcancer</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1"><bold>0.79</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>0.020</bold></td>
<td align="left" rowspan="1" colspan="1">/</td>
<td align="left" rowspan="1" colspan="1">0.77</td>
<td align="left" rowspan="1" colspan="1">0.148</td>
<td align="left" rowspan="1" colspan="1">/</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1"><bold>0.79</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>0.012</bold></td>
<td align="left" rowspan="1" colspan="1">/</td>
<td align="left" rowspan="1" colspan="1">0.85</td>
<td align="left" rowspan="1" colspan="1">0.357</td>
<td align="left" rowspan="1" colspan="1">/</td>
<td align="left" rowspan="1" colspan="1"><bold>0.84</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>0.018</bold></td>
<td align="left" rowspan="1" colspan="1">/</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1"><bold>(0.65–0.96)</bold></td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.54–1.01)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1"><bold>(0.66–0.95)</bold></td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.60–1.20)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1"><bold>(0.72–0.97)</bold></td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ethnicity</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">1.08</td>
<td align="left" rowspan="1" colspan="1">0.410</td>
<td align="left" rowspan="1" colspan="1">72.6 <xref ref-type="table-fn" rid="nt107">c</xref></td>
<td align="left" rowspan="1" colspan="1">0.90</td>
<td align="left" rowspan="1" colspan="1">0.480</td>
<td align="left" rowspan="1" colspan="1">60.0 <xref ref-type="table-fn" rid="nt107">c</xref></td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">1.03</td>
<td align="left" rowspan="1" colspan="1">0.761</td>
<td align="left" rowspan="1" colspan="1">69.3 <xref ref-type="table-fn" rid="nt107">c</xref></td>
<td align="left" rowspan="1" colspan="1">0.86</td>
<td align="left" rowspan="1" colspan="1">0.261</td>
<td align="left" rowspan="1" colspan="1">57.6 <xref ref-type="table-fn" rid="nt107">c</xref></td>
<td align="left" rowspan="1" colspan="1">0.99</td>
<td align="left" rowspan="1" colspan="1">0.895</td>
<td align="left" rowspan="1" colspan="1">67.2 <xref ref-type="table-fn" rid="nt107">c</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.90–1.31)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.68–1.20)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.87–1.21)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.66–1.12)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.87–1.13)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1"><bold>0.84</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>0.003</bold></td>
<td align="left" rowspan="1" colspan="1">3.7 <xref ref-type="table-fn" rid="nt106">b</xref></td>
<td align="left" rowspan="1" colspan="1">0.87</td>
<td align="left" rowspan="1" colspan="1">0.143</td>
<td align="left" rowspan="1" colspan="1">0.0 <xref ref-type="table-fn" rid="nt106">b</xref></td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1"><bold>0.85</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>0.002</bold></td>
<td align="left" rowspan="1" colspan="1">0.0 <xref ref-type="table-fn" rid="nt106">b</xref></td>
<td align="left" rowspan="1" colspan="1">0.95</td>
<td align="left" rowspan="1" colspan="1">0.549</td>
<td align="left" rowspan="1" colspan="1">0.0 <xref ref-type="table-fn" rid="nt106">b</xref></td>
<td align="left" rowspan="1" colspan="1"><bold>0.90</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>0.009</bold></td>
<td align="left" rowspan="1" colspan="1">0.0 <xref ref-type="table-fn" rid="nt106">b</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1"><bold>(0.75–0.94)</bold></td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.73–1.05)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="3" align="left" rowspan="1"><bold>(0.76–0.94)</bold></td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">(0.80–1.13)</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1"><bold>(0.83–0.97)</bold></td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt104"><p>OR: odds ratio; CI: confidence interval. The results were in bold, if the 95% CI excluded 1 or <italic>P</italic>&lt;0.05.</p></fn><fn id="nt105"><label>a</label><p>the statistical significance of the pooled OR was determined by the Z test;</p></fn><fn id="nt106"><label>b</label><p>No statistical significance was found by the heterogeneity test, then the fixed-effects model was adopted here.</p></fn><fn id="nt107"><label>c</label><p>confirmatory analyses with a random-effect model was used if there was significant heterogeneity.</p></fn><fn id="nt108"><label>d</label><p>when the dominant model was analyzed, the data studied by Wenzhang Wang (2011) was added.</p></fn></table-wrap-foot></table-wrap>
<p>In the stratification analysis of cancer type, the variant G allele was observed to be statistically associated with a decreased risk of breast cancer (OR = 0.92, 95% CI = 0.85–0.99). Since only one study was conducted in renal cell cancer or nasopharyngeal cancer <xref ref-type="bibr" rid="pone.0065208-Shi1">[19]</xref><xref ref-type="bibr" rid="pone.0065208-Li1">[38]</xref>, the pooled OR could not be appraised on these two cancer types. Based on single study, we observed that the AG heterozygote and AG/GG genotypes were consistently associated with decreased risks of renal cell cancer (AG vs. AA:OR = 0.70, 95% CI = 0.55–0.89; AG/GG vs. AA: OR = 0.72, 95% CI = 0.57–0.90) and nasopharyngeal cancer (AG vs. AA:OR = 0.79, 95% CI = 0.65–0.96; AG/GG vs. AA: OR = 0.79, 95% CI = 0.66–0.95) when compared with the wild-type AA genotype. In addition, the G allele was statistically associated with decreased risks of renal cell cancer (OR = 0.81, 95% CI = 0.67–0.97) and nasopharyngeal cancer (OR = 0.84, 95% CI = 0.72–0.97) compared with the A allele. These observations insinuated a reverse association of G allele with the risks of those tumor types. Nevertheless, the comparison of AG versus AA in digestive tract cancer subgroup showed an opposite result. The AG genotype was associated with an increased risk of digestive tract cancer (AG vs. AA genotype: OR = 1.16, 95% CI = 1.01–1.32).</p>
<p>In the stratification analysis of ethnicity, when compared with the ancestral AA genotype, the AG heterozygote and AG/GG genotypes were associated with a decreased risk of cancers in Caucasians subgroup (AG vs. AA: OR = 0.84, 95% CI = 0.75–0.94; AG/GG vs. AA: OR = 0.85, 95% CI = 0.76–0.94) but not in Asians subgroup. We observed the same association in the allelic comparison (G allele vs. A allele: OR = 0.90, 95% CI = 0.83–0.97).</p>
</sec><sec id="s3c">
<title>Heterogeneity</title>
<p>The heterogeneity within each subgroup was shown in <xref ref-type="table" rid="pone-0065208-t002">Table 2</xref>. A part of comparisons showed slight or moderate heterogeneities between studies. We subsequently conducted sensitivity analyses to explore individual study’s influence on the pooled results by the removing one study at a time from pooled analysis (<xref ref-type="supplementary-material" rid="pone.0065208.s001">Table S1</xref>). The results showed no individual study affected the pooled OR significantly. We therefore further explored the source of heterogeneity by cancer type, ethnicity, language, and genotyping method with meta-regression in allelic comparison (G vs A). Meta-regression results revealed that cancer type (<italic>P</italic> = 0.023) but not ethnicity (<italic>P</italic> = 0.452), language (<italic>P</italic> = 0.347), or genotyping method (<italic>P = </italic>0.100) contributed to the source of heterogeneity. Additionally, cancer type could explained 85.29% of the between studies variance (τ<sup>2</sup>).</p>
</sec><sec id="s3d">
<title>Publication Bias</title>
<p>Begg’s rank correlation was conducted to evaluate publication bias. In the comparison of AG vs. AA and dominant model (AG/GG versus AA), a slight publication bias was observed (AG vs. AA: <italic>P</italic> = 0.020; AG/GG versus AA: <italic>P</italic> = 0.088, respectively, <xref ref-type="table" rid="pone-0065208-t003">Table 3</xref>), insinuating potential publication bias due to a language bias, inflated estimates by a flawed methodological design in smaller studies, and/or a lack of publication of small trials with opposite results.</p>
<table-wrap id="pone-0065208-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0065208.t003</object-id><label>Table 3</label><caption>
<title>The results of Begg’ s test for the publication bias.</title>
</caption><alternatives><graphic id="pone-0065208-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0065208.t003" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Comparison type for miR-27a rs895819</td>
<td colspan="2" align="left" rowspan="1">Begg’ s test</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Z value</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> value</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">AG vs. AA</td>
<td align="left" rowspan="1" colspan="1">2.33</td>
<td align="left" rowspan="1" colspan="1">0.020</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">GG vs. AA</td>
<td align="left" rowspan="1" colspan="1">−0.41</td>
<td align="left" rowspan="1" colspan="1">0.681</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">AG/GG vs. AA</td>
<td align="left" rowspan="1" colspan="1">1.71</td>
<td align="left" rowspan="1" colspan="1">0.088</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">GG vs. AA/AG</td>
<td align="left" rowspan="1" colspan="1">−1.10</td>
<td align="left" rowspan="1" colspan="1">0.273</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">G vs. A</td>
<td align="left" rowspan="1" colspan="1">0.69</td>
<td align="left" rowspan="1" colspan="1">0.493</td>
</tr>
</tbody>
</table>
</alternatives></table-wrap></sec></sec><sec id="s4">
<title>Discussion</title>
<p>miR-27a, which is located in an intergenic region of chromosome 19 (chr19∶13947254–13947331), had up-regulated expression in many tumors <xref ref-type="bibr" rid="pone.0065208-Ma1">[42]</xref> and was considered to be an oncomir <xref ref-type="bibr" rid="pone.0065208-Liu1">[43]</xref>–<xref ref-type="bibr" rid="pone.0065208-Wang6">[45]</xref>. Using the single-stranded conformational polymorphism-polymerase chain reaction (PCR-SSCP) method Tomiyasu Arisawa discovered in 2007 that there was a polymorphism in the flanking region of miR-27a gene, and the variant G allele frequency reached 34.6% <xref ref-type="bibr" rid="pone.0065208-Arisawa1">[36]</xref>. In the same year, Ranhui Duan et al. employed a bioinformatic method to screen 323 SNPs, and emphasized the importance of this rs895819 SNP because of its location in the pre-miRNA sequence <xref ref-type="bibr" rid="pone.0065208-Duan1">[6]</xref>. Since then, several studies of this SNP emerged in succession. In 2010, Tair Kontorovich et al., using a Sequenom MassARRAY, screened 42 miRNA-related SNPs and found that AG heterozygote of miR-27a rs895819 had a lower risk for breast/ovarian cancer among Jewish women <xref ref-type="bibr" rid="pone.0065208-Kontorovich1">[17]</xref>. At almost the same time, Rongxi Yang et al. used a sequencing method to observe that the variant G allele significantly decreased familial breast cancer risk in a German population <xref ref-type="bibr" rid="pone.0065208-Yang1">[18]</xref>. Following that, it was suggested that the AG and GG genotypes had a decreased renal cell cancer risk in a Chinese population compared with the AA wild-type genotype <xref ref-type="bibr" rid="pone.0065208-Shi1">[19]</xref>. However, some studies hold different viewpoints; a few studies considered the relationship between the variant G allele and the risk of tumor to be insignificant <xref ref-type="bibr" rid="pone.0065208-Zhang1">[20]</xref>–<xref ref-type="bibr" rid="pone.0065208-Catucci1">[22]</xref>. Moreover, some researchers thought that the variant G allele was a risk allele. Two inconsistent studies investigated the risk of gastric cancer using samples from the same country. Qingmin Sun et al. found that the AG and GG genotypes were associated with an increased risk of gastric cancer and an increased expression level of miR-27a <xref ref-type="bibr" rid="pone.0065208-Sun1">[23]</xref>, but Yuan Zhou observed the opposite result <xref ref-type="bibr" rid="pone.0065208-Zhou1">[24]</xref>.</p>
<p>According to our meta-analysis, A→G variation at miR-27a rs895819 polymorphism site did not exert significant genetic effect on cancer risk in the overall analysis (<xref ref-type="table" rid="pone-0065208-t002">Table 2</xref>). We further performed stratification analysis based on cancer type and ethnicity. In breast cancer subgroup analysis integrating 4 studies, subjects carrying G allele of rs895819 demonstrated reduced cancer risk. Additionally, one study about renal cell cancer <xref ref-type="bibr" rid="pone.0065208-Shi1">[19]</xref> and one study on nasopharyngeal cancer <xref ref-type="bibr" rid="pone.0065208-Li1">[38]</xref> could not be incorporated into other cancer types and thus were analyzed separately as single cancer type in this meta-analysis. For renal cell cancer and nasopharyngeal cancer, association analyses under codominant model (AG versus AA), dominant model (AG/GG versus AA) and allelic comparison (G vs. A) consistently supported that this polymorphism was related to decreased risks of both cancers. The slight difference of ORs and 95% CI between our meta-analysis and their original studies was probably due to unavailable raw data for adjustment of other factors. All these findings indicated that this polymorphism may be associated with decreased risks of specific cancers including breast cancer, renal cell carcinoma and nasopharyngeal carcinoma.</p>
<p>In subgroup analysis of digestive tract cancer, however, we observed that AG genotype was associated with increased cancer risk. As for the single original study, Sun et al ’s <xref ref-type="bibr" rid="pone.0065208-Sun1">[23]</xref> reported a statistically positive association of rs895819 polymorphism with gastric cancer risk; four studies <xref ref-type="bibr" rid="pone.0065208-Sun1">[23]</xref>, <xref ref-type="bibr" rid="pone.0065208-Zhang2">[37]</xref>, <xref ref-type="bibr" rid="pone.0065208-Li1">[38]</xref> (Qian Xu, 2013<sup>*</sup>) showed that this polymorphism tended to be positively associated with higher risks of digestive tract cancers, although they did not reach statistical significance. In this meta-analysis, we incorporated and evaluated the available data of this polymorphism with digestive tract cancer risk, which may demonstrate a relatively stable result. The difference of the association of this polymorphism with various cancers may result from distinct cell origin and pathogenetic mechanisms of different cancers.</p>
<p>To better elucidate the association of this polymorphism with digestive tract cancer, we added a set of unpublished data which was a case-control study including 222 gastric cancer cases and 305 superficial gastritis patients as controls in Chinese. The control group contained participants from a health check program for gastric cancer screening in Zhuanghe region of Liaoning Province, China and patients who underwent gastroscopic examination in the First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China. All the 527 subjects were diagnosed independently by two professorial pathologists. By integrating currently-published 6 studies and our newly-unpublished data, we found for the first time that this polymorphism may be associated with digestive tract cancer, which is also one of the differences between our meta-analysis and previously published meta-analyses. Furthermore, considering the relatively obvious heterogeneity observed in this meta-analysis even after employing sensitivity analyses and subgroup analyses, we carried out meta-regression to further explore the source of heterogeneity. Interestingly, the results of meta-regression indicated the heterogeneity mainly resulted from different cancer types and this variance could explain the majority of heterogeneity origin. Therefore, the different effects of this polymorphism on various cancers should not be overlooked and its specific effects on different cancer types are warranted to be clarified in future research.</p>
<p>Limitations of this study should also be noted. First, we pooled the data using unadjusted information, whereas a more precise analysis could to be conducted if detailed information of original data is available. Second, a lack of original data of the reviewed studies limited our further evaluation of potential interactions, including the interactions between different genes and between gene and environment factors. Third, only English and Chinese documents and our unpublished study were included in this meta-analysis, while reports that were written in other languages and other unpublished data or ongoing studies were not available, which may cause certain publication bias in our meta-analysis. The last but not the least, the pooled sample size was relatively limited in this meta-analysis. Therefore, this meta-analysis could only preliminarily appraise the association of rs895819 polymorphism with currently-reported cancers. More studies are still required to get a more reliable result.</p>
<p>In summary, this meta-analysis indicated that the G allele of miR-27a rs895819 polymorphism may be associated with decreased risks of breast cancer, renal cell cancer and nasopharyngeal cancer, as well as a decreased cancer risk in Caucasians and AG heterozygote might be associated with an increased risk of digestive tract cancer. To confirm our findings, additional well-designed studies in diverse ethnic populations and functional studies regarding this SNP are required.</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pone.0065208.s001" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0065208.s001" position="float" xlink:type="simple"><label>Table S1</label><caption>
<p><bold>ORs (95% CI) of sensitivity analysis.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material><supplementary-material id="pone.0065208.s002" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0065208.s002" position="float" xlink:type="simple"><label>Table S2</label><caption>
<p><bold>Checklist of this meta-analysis.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0065208-Zanetti1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zanetti</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Haznadar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Welsh</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Robles</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>BM</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>3′-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans</article-title>. <source>Cancer Res</source> <volume>72</volume>: <fpage>1467</fpage>–<lpage>1477</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Khvorova1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Khvorova</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Reynolds</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jayasena</surname><given-names>SD</given-names></name> (<year>2003</year>) <article-title>Functional siRNAs and miRNAs exhibit strand bias</article-title>. <source>Cell</source> <volume>115</volume>: <fpage>209</fpage>–<lpage>216</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Higgins1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2003</year>) <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>Bmj</source> <volume>327</volume>: <fpage>557</fpage>–<lpage>560</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Lee1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ahn</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>The nuclear RNase III Drosha initiates microRNA processing</article-title>. <source>Nature</source> <volume>425</volume>: <fpage>415</fpage>–<lpage>419</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Schwarz1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schwarz</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Hutvagner</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Aronin</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Asymmetry in the assembly of the RNAi enzyme complex</article-title>. <source>Cell</source> <volume>115</volume>: <fpage>199</fpage>–<lpage>208</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Duan1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pak</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>P</given-names></name> (<year>2007</year>) <article-title>Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA</article-title>. <source>Hum Mol Genet</source> <volume>16</volume>: <fpage>1124</fpage>–<lpage>1131</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Wang1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Qian</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>The association between hsa-miR-499 T&gt;C polymorphism and cancer risk: a meta-analysis</article-title>. <source>Gene</source> <volume>508</volume>: <fpage>9</fpage>–<lpage>14</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Lian1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lian</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name> (<year>2012</year>) <article-title>Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans</article-title>. <source>PLoS One</source> <volume>7</volume>: <fpage>e31615</fpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Guo1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>K</given-names></name> (<year>2012</year>) <article-title>A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-analysis of 15 case-control studies</article-title>. <source>PLoS One</source> <volume>7</volume>: <fpage>e30585</fpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Qiu1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Qiu</surname><given-names>LX</given-names></name>, <name name-style="western"><surname>He</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>RX</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>TY</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>The association between common genetic variant of microRNA-146a and cancer susceptibility</article-title>. <source>Cytokine</source> <volume>56</volume>: <fpage>695</fpage>–<lpage>698</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Wang2"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Di</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies</article-title>. <source>Mol Biol Rep</source> <volume>39</volume>: <fpage>4571</fpage>–<lpage>4579</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Qiu2"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Qiu</surname><given-names>LX</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>ZG</given-names></name>, <name name-style="western"><surname>Xi</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Mao</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>miR-196a2 C allele is a low-penetrant risk factor for cancer development</article-title>. <source>Cytokine</source> <volume>56</volume>: <fpage>589</fpage>–<lpage>592</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Xu1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis</article-title>. <source>PLoS One</source> <volume>6</volume>: <fpage>e20471</fpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Wang3"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>YL</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>HQ</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis</article-title>. <source>Mol Biol Rep</source> <volume>39</volume>: <fpage>269</fpage>–<lpage>275</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Chu1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies</article-title>. <source>PLoS One</source> <volume>6</volume>: <fpage>e18108</fpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Gao1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gao</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Bai</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>XM</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>LJ</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis</article-title>. <source>Breast Cancer Res Treat</source> <volume>125</volume>: <fpage>571</fpage>–<lpage>574</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Kontorovich1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kontorovich</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Levy</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Korostishevsky</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nir</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Friedman</surname><given-names>E</given-names></name> (<year>2010</year>) <article-title>Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women</article-title>. <source>Int J Cancer</source> <volume>127</volume>: <fpage>589</fpage>–<lpage>597</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Yang1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Schlehe</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hemminki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sutter</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bugert</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk</article-title>. <source>Breast Cancer Res Treat</source> <volume>121</volume>: <fpage>693</fpage>–<lpage>702</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Shi1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shi</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>A Genetic Variant in pre-miR-27a Is Associated with a Reduced Renal Cell Cancer Risk in a Chinese Population</article-title>. <source>PLoS One</source> <volume>7</volume>: <fpage>e46566</fpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Zhang1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population</article-title>. <source>Eur J Cancer Care (Engl)</source> <volume>21</volume>: <fpage>274</fpage>–<lpage>280</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Hezova1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hezova</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kovarikova</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bienertova-Vasku</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sachlova</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Redova</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer</article-title>. <source>World J Gastroenterol</source> <volume>18</volume>: <fpage>2827</fpage>–<lpage>2831</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Catucci1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Catucci</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Verderio</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pizzamiglio</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bernard</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Dall'olio</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians</article-title>. <source>Breast Cancer Res Treat</source> <volume>133</volume>: <fpage>805</fpage>–<lpage>807</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Sun1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sun</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression</article-title>. <source>Cancer Sci</source> <volume>101</volume>: <fpage>2241</fpage>–<lpage>2247</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Zhou1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>WD</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ruan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Association analysis of genetic variants in microRNA networks and gastric cancer risk in a Chinese Han population</article-title>. <source>J Cancer Res Clin Oncol</source> <volume>138</volume>: <fpage>939</fpage>–<lpage>945</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Lau1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lau</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ioannidis</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Schmid</surname><given-names>CH</given-names></name> (<year>1997</year>) <article-title>Quantitative synthesis in systematic reviews</article-title>. <source>Ann Intern Med</source> <volume>127</volume>: <fpage>820</fpage>–<lpage>826</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-DerSimonian1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname><given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Mantel1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mantel</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Haenszel</surname><given-names>W</given-names></name> (<year>1959</year>) <article-title>Statistical aspects of the analysis of data from retrospective studies of disease</article-title>. <source>J Natl Cancer Inst</source> <volume>22</volume>: <fpage>719</fpage>–<lpage>748</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Whitehead1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Whitehead</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Whitehead</surname><given-names>J</given-names></name> (<year>1991</year>) <article-title>A general parametric approach to the meta-analysis of randomized clinical trials</article-title>. <source>Stat Med</source> <volume>10</volume>: <fpage>1665</fpage>–<lpage>1677</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Begg1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Zhong1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhong</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name> (<year>2013</year>) <article-title>Pre-mir-27a rs895819 polymorphism and cancer risk: a meta-analysis</article-title>. <source>Mol Biol Rep</source> <volume>40</volume>: <fpage>3181</fpage>–<lpage>3186</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Yang2"><label>31</label>
<mixed-citation publication-type="other" xlink:type="simple">Yang Q, Jie Z, Ye S, Li Z, Han Z, <etal>et al</etal>.. (2012) Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. Oncogene [Epub ahead of print].</mixed-citation>
</ref>
<ref id="pone.0065208-Yoon1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yoon</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jang</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Zo</surname><given-names>JI</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer</article-title>. <source>J Thorac Cardiovasc Surg</source> <volume>144</volume>: <fpage>794</fpage>–<lpage>807</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Yang3"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Burwinkel</surname><given-names>B</given-names></name> (<year>2012</year>) <article-title>A bias in genotyping the miR-27a rs895819 and rs11671784 variants</article-title>. <source>Breast Cancer Res Treat</source> <volume>134</volume>: <fpage>899</fpage>–<lpage>901</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Hirota1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hirota</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Date</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nishibatake</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Takane</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fukuoka</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues</article-title>. <source>Lung Cancer</source> <volume>77</volume>: <fpage>16</fpage>–<lpage>23</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Jahid1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jahid</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Dizon</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Panarelli</surname><given-names>NC</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>miR-23a promotes the transition from indolent to invasive colorectal cancer</article-title>. <source>Cancer Discov</source> <volume>2</volume>: <fpage>540</fpage>–<lpage>553</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Arisawa1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Arisawa</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tahara</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Shibata</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nagasaka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>A polymorphism of microRNA 27a genome region is associated with the development of gastric mucosal atrophy in Japanese male subjects</article-title>. <source>Dig Dis Sci</source> <volume>52</volume>: <fpage>1691</fpage>–<lpage>1697</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Zhang2"><label>37</label>
<mixed-citation publication-type="other" xlink:type="simple">Zhang M-w (2012) Study on the Associations of Lifestyle-related Factors,Gentic Variants in miRNA Encoding Regions and miRNA Binding Sites with Colorectal Cancer Risk. Zhejiang University: [D] Zhejiang.</mixed-citation>
</ref>
<ref id="pone.0065208-Li1"><label>38</label>
<mixed-citation publication-type="other" xlink:type="simple">Li P-r (2011) Genetic Associations of miRNA-SNPs with the Common Diseases and Integrative Analysis of "OMICS" Data of Hepatocellular Carcinoma. Academy of Military Medical Sciences in the People’s Liberarion Army: [D] Beijing.</mixed-citation>
</ref>
<ref id="pone.0065208-Zhang3"><label>39</label>
<mixed-citation publication-type="other" xlink:type="simple">Zhang P (2011) Polymorphisms of MicroRNA and ESR1 Genes and Their Association with Triple Negative Breast Cancer Risk and Prognosis. Chinese Academy of Medical Sciences (Beijing Union Medical College): [D] Beijing.</mixed-citation>
</ref>
<ref id="pone.0065208-Wang4"><label>40</label>
<mixed-citation publication-type="other" xlink:type="simple">Wang W-z (2011) The Association of miR-146a Single Nucleotide Polymorphisms and Genetic Susceptibility of Liver Cancer and Study of Tumor-associaed microRNA Microarray analysis. Fudan University: [D] Shanghai.</mixed-citation>
</ref>
<ref id="pone.0065208-Wang5"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name> (<year>2012</year>) <article-title>Association Between the hsa-mir-27a Variant and Breast Cancer Risk: a Meta-analysis</article-title>. <source>Asian Pac J Cancer Prev</source> <volume>13</volume>: <fpage>6207</fpage>–<lpage>6210</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Ma1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name> (<year>2010</year>) <article-title>miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2</article-title>. <source>Cancer Lett</source> <volume>298</volume>: <fpage>150</fpage>–<lpage>158</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Liu1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name> (<year>2009</year>) <article-title>MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin</article-title>. <source>Cancer Lett</source> <volume>273</volume>: <fpage>233</fpage>–<lpage>242</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Zhang4"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>G</given-names></name> (<year>2009</year>) <article-title>miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition</article-title>. <source>Cancer Genet</source> <volume>204</volume>: <fpage>486</fpage>–<lpage>491</lpage>.</mixed-citation>
</ref>
<ref id="pone.0065208-Wang6"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>ZF</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>CX</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>YM</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen</article-title>. <source>Oncogene</source> <volume>30</volume>: <fpage>3875</fpage>–<lpage>3886</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>